Staging of cutaneous melanoma
Peter Mohr(Elbe Kliniken Stade-Buxtehude), Antônio C. Buzaid(Johns Hopkins University), Axel Hauschild(University Hospital Schleswig-Holstein), Alexander M.M. Eggermont(University Medical Center Utrecht)
Cited by 100
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k